- Case report
- Open Open Peer Review
Soft tissue regeneration using leukocyte-platelet rich fibrin after exeresis of hyperplastic gingival lesions: two case reports
Journal of Medical Case Reportsvolume 9, Article number: 252 (2015)
Leukocyte-platelet rich fibrin belongs to a second generation of platelet concentrates that does not need biochemical blood manipulation. It is used for tissue healing and regeneration in periodontal and oral-maxillofacial surgery. We report two cases of hyperplastic gingival lesions treated by exeresis and application of leukocyte-platelet rich fibrin membranes in order to improve and accelerate tissue healing.
Two patients (a 78-year-old Caucasian woman and a 30-year-old Caucasian man) were treated for hyperplastic gingival lesions. They underwent to exeresis of lesions and application of leukocyte-platelet rich fibrin membranes. Tissue healing was clinically evaluated after 1, 3, 7, 14 and 30 postoperative days. No recurrences were observed after 2 years of semi-annual follow up.
We obtained rapid and good healing of soft tissues probably due to the elevated content of leukocytes, platelets and growth factors in the leukocyte-platelet rich fibrin. Based on our results we suggest the use of leukocyte-platelet rich fibrin to cover wounds after exeresis of oral neoformations such as hyperplastic gingival lesions.
Hyperplastic gingival lesions consist of fibro-epithelial reactions that are secondary to multiple factors: chronic inflammation, local irritation (e.g. dental plaque, tartar, root residues, projecting fillings and reconstructions, incongruous dentures), hormonal factors (puberty, pregnancy), and drugs such as anti-epileptic drugs (diphenylhydantoin sodium, valproate sodium, carbamazepine), immunosuppressive drugs (ciclosporin) and antianginal vasodilators (nifedipine) [1, 2]. A dysplastic hypothesis has been formulated regarding its onset [3, 4]; this hypothesis is suggested by the tendency of some hyperplastic gingival lesions to grow and not to regress spontaneously. They tend to recur unless a radical surgical therapy is performed. Examples of these lesions are giant-cell epulis and fibro-osseous epulis. Giant-cell epulis is the most common form and it is also called peripheral giant-cell granuloma (PGCG). It was first reported as fungus flesh in 1848 , then reported as giant cell reparative granuloma in 1953 . This lesion is the peripheral opponent form of central giant-cell intraosseous tumors, characterized by the presence of giant cells that seem to originate from osteoclasts in the periodontal ligament . Fibro-osseous epulis or peripheral ossifying fibroma (POsF) was first reported and described as ‘alveolar exostosis’ in 1844 . It presents a dense collagenous stroma in which thin trabecular bone can be observed.
We report two cases of hyperplastic gingival lesions treated by exeresis and application of leukocyte-platelet rich fibrin (L-PRF) membranes in order to improve and accelerate tissue healing. L-PRF belongs to a second generation of platelet concentrates which does not need biochemical blood manipulation [9, 10]. It is used for tissue healing [11, 12] and regeneration in periodontal and oral-maxillofacial surgery  because of its elevated content of leukocytes, platelets and growth factors.
Case number one
A 78-year-old Caucasian woman presented with a complaint of a swelling in her right mandibular molar teeth area that was painful at mastication. The swelling had arisen 4 months previously and had grown quickly. On extraoral examination she presented a right facial swelling and the skin of her face was healthy. Her regional lymph nodes were not palpable. On intraoral examination she showed poor oral hygiene. A 45×30×20mm sessile, lobular, soft tissue mass was evident in her right posterior mandibular gingiva (Fig. 1). The mucosal covering of the lesion looked rosy-purple with a focal area of ulceration. The lesion was painful and bleeding on palpation with a parenchymatous consistency. At orthopantomography two premolar residual roots were observed in the area of the lesion (Fig. 2) with no other significant findings.
Case number two
A 30-year-old Caucasian man presented with a complaint of a swelling in his left hard palate region which had arisen approximately 2 months previously after contact with hot food. The lesion was not painful but was responsible for discomfort on swallowing and phonation. On extraoral examination facial skin lesions or swellings were not highlighted and his regional lymph nodes were not palpable. An intraoral examination showed a sessile and detected lesion of hard palate in correspondence with left maxillary lateral incisor, left maxillary canine and left maxillary first premolar. The lesion was characterized by a diameter of 10mm and the mucosa which covered it looked eutrophic (Fig. 3). The lesion was not painful on palpation and it had a hard consistency. He showed good level of oral hygiene. The adjacent teeth did not have carious or periodontal lesions and they responded positively to the vitality test. At orthopantomography no signs of pathology were found.
In both cases we decided to proceed with a surgical approach characterized by complete excision of lesions and application of L-PRF membranes in order to improve and accelerate tissue healing.
Prior antibiotic therapy with amoxicillin clavulanate (2g 1 hour before operation) infiltrative anesthesia (mepivacaine 30mg/mL and epinephrine 0.01mg/mL) was performed. Full thickness incisions were realized by Bard-Parker blades number 15 and they included at least 2 mm of healthy tissue. The lesions strongly adhered to the floor below. They were lifted by Prichard’s periosteal spatulas and surgical tweezers (Fig. 4). At the same time blood samples (40cc per patient) were collected in test tubes without anticoagulant to obtain the L-PRF. L-PRF protocol  is realized with the Intra-Spin L-PRF which provides blood centrifugation at 2700 revolutions per minute (rpm) for 12 minutes. Centrifugation determines the formation of the clot and the activation of the growth factors. After centrifugation L-PRF clots were collected together with some red blood cells from the test tubes using sterile scissors. L-PRF clots were compressed between two sterile gauzes to obtain manageable membranes useful to cover the wounds. The L-PRF membranes were stabilized with horizontal mattress and single sutures in Vicryl 3/0 (Figs. 5 and 6) removed after 7 days. After the surgery, the patients were encouraged to take, in case of pain, acetaminophen (1g/8 hours) or ibuprofen (600mg/8 hours) and a collutory with chlorhexidine 0.20% was prescribed for 7 days. Tissue healing was clinically evaluated after 1, 3, 7, 14 and 30 postoperative days (Fig. 7). Healing was quick and without dehiscences. Therefore, complete excision of the lesion was performed and the entire specimen submitted for histopathological examination (Fig. 8). Histological reports highlighted giant-cell epulis for the first case and fibro-osseous epulis for the second case. No recurrences were observed after 2 years of semi-annual follow up (Figs. 9 and 10).
Although the epulis in its form of giant-cell epulis and fibro-osseous epulis is a benign disease, it is important to find time to make the correct therapy. Both young and old patients must take prompt actions to avoid growth of oral lesions that can begin to become difficult to manage. There is unanimous consensus on the surgical excision of these lesions in toto to prevent recurrence. The target of these case reports is to focus on the management of the L-PRF and its placement on the surgical wounds. The first benefit is given by covering the surgical site, which would otherwise heal by secondary intention, which provides greater comfort to the patient in the postoperative period. The same wound healing appears to be substantially accelerated because of the structural and neoangiogenetical properties of L-PRF . In the polymerization step of the L-PRF, thrombin, which is present in physiological concentrations, allows the formation of a fibrin matrix in a slow and natural way obtaining a flexible structure capable of determining entrapment of cytokines, cell migration and tissue healing . The effect of L-PRF on reducing pain and postoperative swelling has the same importance. There are countless practices that the L-PRF offers in the dental field such as the accelerated healing of extraction sockets and use with other biomaterials in bone regeneration (GBR) . In the context of tissue regeneration we evaluated the role of L-PRF in the promotion of wound healing. We also stress the importance of such a gel in the control of hemostasis in patients taking anti-platelets and/or anticoagulants for whom extractions can be performed without discontinuation of these drugs.
According to the encouraging results obtained in these two clinical cases about tissue healing after application of L-PRF membranes, we suggest that L-PRF be used to cover wounds after exeresis of oral neoformations such as hyperplastic gingival lesions.
Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Ficarra G. Manuale di Patologia e Medicina Orale. McGraw-Hill Education. 2006. Milano, Italy.
di Lauro F, Bucci E. Chirurgia Odontostomatologica. Ed. Florio. 2000. Naples, Italy.
Ramu S, Rodrigues C. Reactive hyperplastic lesions of the gingiva: a retrospective study of 260 cases. World J Dent. 2012;3(2):126–30.
Chaparro–Averdano A, Berini-Aytes L, Gay–Escoda C. Peripheral giant cell granuloma. A report of five case and review of the literature. Med Oral Patol Oral Cir Bucal. 2005;10(1):53–7.
Tomes J. A course of lectures on dental physiology and surgery (lectures I–XV). Am J Dent Sci. 1846–1848;7:1–68. 121–134, 33–54, 120–147, 313–350.
Jaffe HL. Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-osseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol. 1953;6:159–75.
Katsikeris N, Kakarantza-Angelopoulou E, Angelopoulos AP. Peripheral giant cell. Granuloma: clinicopathologic study of 224 new cases and review of 956 reported cases. Int J Oral Maxillofac Surg. 1988;17:94–9.
Shepherd SM. Alveolar exostosis. Am J Dent Sci. 1844;4:43–4.
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):e37–44.
Dohan Ehrenfest DM, Bielecki T, Mishra A, Borzini P, Inchingolo F, Sammartino G, et al. In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes. Curr Pharm Biotechnol. 2012;13(7):1131–7.
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):e56–60.
Anitua E, Andia I, Ardonza B, Nurden P. Autologous platelet as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91(1):4–15.
Simonpieri A, Del Corso M, Vervelle A, Jimbo R, Inchingolo F, Sammartino G, et al. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery. Curr Pharm Biotechnol. 2012;13(7):1231–56.
Clark RA. Fibrin and wound healing. Ann N Y Acad Sci. 2001;936:355–67.
Cassling VL, Açil Y, Springer IN, Hubert N, Wiltfang J. Platelet-rich plasma and platelet-rich fibrin in human cell culture. Pathol Oral Radiol Endod. 2009;108(1):48–55.
Tatullo M, Marrelli M. Platelet rich fibrin in reconstructive surgery of atrophied maxillary bones: clinical and histological evaluators. Int J Med Sci. 2012;9(10):872–80.
We have not received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript.
AEdL conceived the study and was the first surgeon/operator; DA was the second surgeon/operator; BDA was the third surgeon/operator; GAI participated in the realization and organization of the pictures; FS participated in the realization of the manuscript; GS participated in the coordination of the study. All authors read and approved the final manuscript.